Delivery Order SPE2DB20D2104-SPE2DB24FMBNR

Award Date 9/16/24
Potential Completion Date 9/17/24
Potential Value $2.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the procurement of VIGAMOX 0.5% eye drops, a medical product used in the treatment of various eye conditions. The contract has a ceiling value of $2,728.56 and a performance period through May 1, 2023. This delivery order contract is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,784.03, is for the supply of VIGAMOX 0.5% eye drops. The delivery order falls under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive...
This is a $2,681.72 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of VIGAMOX 0.5% eye drops, a prescription ophthalmic medication. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of VIGAMOX 0.5% eye drops (3ml). The contract has a ceiling value of $24,793.95 and a period of performance through June 12, 2025. The contract is not set aside and is an open competition award. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $4,349.48 firm fixed-price contract is for the supply of Vigamox 0.5% eye drops, a medication used to treat bacterial eye infections. The contract has an ultimate completion date of April 19, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $4,516.37 firm-fixed-price contract is for the supply of Vigamox 0.5% eye drops, a specialty pharmaceutical product. The contract has an ultimate completion date of April 21, 2023. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of VIGAMOX 0.5% eye drops, a pharmaceutical product, with a ceiling value of $1,552.88 and a period of performance through April 3, 2024. This order is issued under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with a potential value of $999,999,999.00...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $10,073.35 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VIGAMOX 0.5% eye drops (3 mL). This award is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Vigamox 0.5% eye drops. The contract has a firm-fixed price of $10,031.27 and a performance period through April 4, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of VIGAMOX 0.5% eye drops. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $5,593.77 and an ultimate completion date of March 27, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB24FMBNR
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of VIGAMOX 0.5% eye drops, a specialty pharmaceutical product. The contract has a firm fixed price of $2,482.87 and runs through September 17, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and spanning through November 2026. The IDC covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen is the prime contractor, and the contract is focused on providing essential medical commodities, including specialty medications, generic drugs, and medical devices, to military treatment facilities, veterans' healthcare programs, and other federal medical institutions.

Generated 2/27/25, 10:20 AM